116 related articles for article (PubMed ID: 38885280)
21. Genomic and virulence analysis of in vitro cultured Cryptosporidium parvum.
Yarlett N; Morada M; Schaefer DA; Ackman K; Carranza E; Baptista RP; Riggs MW; Kissinger JC
PLoS Pathog; 2024 Feb; 20(2):e1011992. PubMed ID: 38416794
[TBL] [Abstract][Full Text] [Related]
22. Morpholino-mediated in vivo silencing of Cryptosporidium parvum lactate dehydrogenase decreases oocyst shedding and infectivity.
Zhang X; Kim CY; Worthen T; Witola WH
Int J Parasitol; 2018 Jul; 48(8):649-656. PubMed ID: 29530646
[TBL] [Abstract][Full Text] [Related]
23. Labeling surface epitopes to identify Cryptosporidium life stages using a scanning electron microscopy-based immunogold approach.
Edwards H; Thompson RC; Koh WH; Clode PL
Mol Cell Probes; 2012 Feb; 26(1):21-8. PubMed ID: 22100878
[TBL] [Abstract][Full Text] [Related]
24. A Conditional Protein Degradation System To Study Essential Gene Function in Cryptosporidium parvum.
Choudhary HH; Nava MG; Gartlan BE; Rose S; Vinayak S
mBio; 2020 Aug; 11(4):. PubMed ID: 32843543
[No Abstract] [Full Text] [Related]
25. Glycoproteins and Gal-GalNAc cause Cryptosporidium to switch from an invasive sporozoite to a replicative trophozoite.
Edwinson A; Widmer G; McEvoy J
Int J Parasitol; 2016 Jan; 46(1):67-74. PubMed ID: 26432292
[TBL] [Abstract][Full Text] [Related]
26. In Vitro Culture of Cryptosporidium parvum Using Stem Cell-Derived Intestinal Epithelial Monolayers.
Wilke G; Wang Y; Ravindran S; Stappenbeck T; Witola WH; Sibley LD
Methods Mol Biol; 2020; 2052():351-372. PubMed ID: 31452172
[TBL] [Abstract][Full Text] [Related]
27. Common occurrence of divergent Cryptosporidium species and Cryptosporidium parvum subtypes in farmed bamboo rats (Rhizomys sinensis).
Li F; Zhang Z; Hu S; Zhao W; Zhao J; Kváč M; Guo Y; Li N; Feng Y; Xiao L
Parasit Vectors; 2020 Mar; 13(1):149. PubMed ID: 32204732
[TBL] [Abstract][Full Text] [Related]
28. Virulence of geographically different Cryptosporidium parvum isolates in experimental animal model.
Sayed FG; Hamza AI; Galal LA; Sayed DM; Gaber M
Ann Parasitol; 2016 Oct; 62(3):221-32. PubMed ID: 27770762
[TBL] [Abstract][Full Text] [Related]
29. Real-time nucleic acid sequence-based amplification (NASBA) assay targeting MIC1 for detection of Cryptosporidium parvum and Cryptosporidium hominis oocysts.
Hønsvall BK; Robertson LJ
Exp Parasitol; 2017 Jan; 172():61-67. PubMed ID: 27998735
[TBL] [Abstract][Full Text] [Related]
30. Host cell tropism underlies species restriction of human and bovine Cryptosporidium parvum genotypes.
Hashim A; Clyne M; Mulcahy G; Akiyoshi D; Chalmers R; Bourke B
Infect Immun; 2004 Oct; 72(10):6125-31. PubMed ID: 15385517
[TBL] [Abstract][Full Text] [Related]
31. Cryptosporidium parvum Elongation Factor 1α Participates in the Formation of Base Structure at the Infection Site During Invasion.
Yu X; Guo F; Mouneimne RB; Zhu G
J Infect Dis; 2020 May; 221(11):1816-1825. PubMed ID: 31872225
[TBL] [Abstract][Full Text] [Related]
32. Inactivation kinetics of Cryptosporidium parvum oocysts in a swine waste lagoon and spray field.
Jenkins MB; Liotta JL; Bowman DD
J Parasitol; 2013 Apr; 99(2):337-42. PubMed ID: 23016982
[TBL] [Abstract][Full Text] [Related]
33. Genotyping of Cryptosporidium parvum with microsatellite markers.
Widmer G; Feng X; Tanriverdi S
Methods Mol Biol; 2004; 268():177-87. PubMed ID: 15156029
[TBL] [Abstract][Full Text] [Related]
34. Quantitative evaluation of infectivity change of Cryptosporidium parvum after gamma irradiation.
Lee SU; Joung M; Nam T; Park WY; Yu JR
Korean J Parasitol; 2009 Mar; 47(1):7-11. PubMed ID: 19290085
[TBL] [Abstract][Full Text] [Related]
35. High-yield amplification of Cryptosporidium parvum in interferon gamma receptor knockout mice.
von Oettingen J; Nath-Chowdhury M; Ward BJ; Rodloff AC; Arrowood MJ; Ndao M
Parasitology; 2008 Sep; 135(10):1151-6. PubMed ID: 18667105
[TBL] [Abstract][Full Text] [Related]
36. Comparative genome analysis of two Cryptosporidium parvum isolates with different host range.
Widmer G; Lee Y; Hunt P; Martinelli A; Tolkoff M; Bodi K
Infect Genet Evol; 2012 Aug; 12(6):1213-21. PubMed ID: 22522000
[TBL] [Abstract][Full Text] [Related]
37. Comparison of resistance to γ-irradiation between Cryptosporidium parvum and Cryptosporidium muris using in vivo infection.
Yoon S; Yu JR
Korean J Parasitol; 2011 Dec; 49(4):423-6. PubMed ID: 22355212
[TBL] [Abstract][Full Text] [Related]
38. Genetic basis for virulence differences of various Cryptosporidium parvum carcinogenic isolates.
Audebert C; Bonardi F; Caboche S; Guyot K; Touzet H; Merlin S; Gantois N; Creusy C; Meloni D; Mouray A; Viscogliosi E; Certad G; Benamrouz-Vanneste S; Chabé M
Sci Rep; 2020 Apr; 10(1):7316. PubMed ID: 32355272
[TBL] [Abstract][Full Text] [Related]
39. Apical Secretory Glycoprotein Complex Contributes to Cell Attachment and Entry by Cryptosporidium parvum.
Akey ME; Xu R; Ravindran S; Funkhouser-Jones L; Sibley LD
mBio; 2023 Feb; 14(1):e0306422. PubMed ID: 36722968
[TBL] [Abstract][Full Text] [Related]
40. The suppressive effect of Mekabu fucoidan on an attachment of Cryptosporidium parvum oocysts to the intestinal epithelial cells in neonatal mice.
Maruyama H; Tanaka M; Hashimoto M; Inoue M; Sasahara T
Life Sci; 2007 Jan; 80(8):775-81. PubMed ID: 17157323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
